Northwest, Lonza Battle Over Gene Patents
Cancer treatment developer Northwest Biotherapeutics Inc. plans to dispute a patent infringement suit filed last week by rival biotechnology company Lonza Group AG, Northwest said Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article